Compliance

RedHill Biopharma Ltd., known for its focus on gastrointestinal and infectious diseases, has recently achieved compliance with Nasdaq's minimum bid price requirement. This milestone ensures that the specialty biopharmaceutical company will continue to be listed on the Nasdaq Capital Market, a

In a move that promises to set new standards in supply chain sustainability, DHL Supply Chain has joined forces with biopharmaceutical company Boehringer Ingelheim to transform its warehousing and logistics operations in Australia and New Zealand. The partnership aims to enhance efficiency,

The recent decision by the Supreme Court to overturn the Chevron doctrine marks a significant shift in administrative law, with profound implications for the healthcare industry, particularly for federal regulators like the FDA (Food and Drug Administration) and the CMS (Centers for Medicare

Cybersecurity in the pharmaceutical industry has never been more imperative. The urgency of protecting sensitive data, ranging from proprietary research to personal patient details, is heightened by the increasing sophistication of cyber threats. With the advent of the COVID-19 pandemic,

The biopharmaceutical and life sciences industry is experiencing dynamic shifts, marked by strategic partnerships, innovative laboratory products, and enhanced service offerings. Companies are increasingly focusing on forming alliances, introducing state-of-the-art equipment, and improving their

The Industrial Internet of Things (IIoT) is revolutionizing biomanufacturing, a crucial element of the broader movement toward Industry 4.0. By leveraging the power of interconnected devices and systems, bioprocessing facilities are experiencing a surge in productivity and operational efficiency.